Piroxicam and Cisplatin Show Promise Against Mesothelioma Cells

Piroxicam, a nonsteroidal anti-inflammatory drug (NSAID), has shown anti-tumoral activity which is amplified when combined with Cisplatin. Researchers used two mesothelioma cell lines and treated cells with piroxicam and cisplatin alone then combined the two treatments. Cell growth was significantly limited in both lines and treatment with either agent appeared to disrupt cell cycle phase… Continue reading Piroxicam and Cisplatin Show Promise Against Mesothelioma Cells

Study: Disappointing Results for Mesothelioma and Chemotherapy

A study in the newest issue of The Lancet concluded that adding chemotherapy to other treatments given to mesothelioma patients does not appear to affect survival or quality of life. Patients suffering from malignant pleural mesothelioma were separated into three groups. The first was given a weekly injection of vinorelbine while the second was a… Continue reading Study: Disappointing Results for Mesothelioma and Chemotherapy